Canbridge Life Sciences

Developer of therapeutics for rare diseases and cancer

placeBeijing, Beijing, China calendar_todayFounded 2012 groups17 employees language canbridgepharma.com

Registered entities

Social engagement

Social engagement: 3.1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

17 investors on record; lead investors include General Atlantic, WuXi AppTec, Yingke Capital, Qiming Venture Partners.

Investor typeCountShare
Venture capital635%
Private equity318%
Bank & private debt212%
Other / undisclosed635%
Coming soon